CHAMPIONS ONCOLOGY, INC. (CSBR) Form 10-K Annual Reports
CHAMPIONS ONCOLOGY, INC. (CSBR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CSBR
CIK: 771856
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 04/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 4/30/2017 12:00:00 AM
Lead Engagement PartnerDean Katsoupas
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001628280-26-066091 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-14 | 8-K | 0001628280-26-066087 | View SEC Doc Filr Page |
| 10-Q | 2026-09-11 | 2026-07-31 | 10-Q | 0001628280-26-061519 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | 8-K | 0001628280-26-061383 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-28 | — | DEFA14A | 0001628280-26-059374 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-28 | 2026-08-27 | DEF 14A | 0001628280-26-059373 | View SEC Doc Filr Page |
| 10-K | 2026-07-27 | 2026-04-30 | 10-K | 0001628280-26-049834 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | 8-K | 0001628280-26-049822 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-24 | 8-K | 0001628280-26-021941 | View SEC Doc Filr Page |
| 10-Q | 2026-03-12 | 2026-01-31 | 10-Q | 0001628280-26-017345 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-12 | 8-K | 0001628280-26-017259 | View SEC Doc Filr Page |
| 4 | 2026-01-30 | 2025-07-16 | FORM 4 | 0001628280-26-004381 | View SEC Doc Filr Page |
| 4 | 2026-01-30 | 2021-11-05 | FORM 4 | 0001628280-26-004342 | View SEC Doc Filr Page |
| 3 | 2026-01-16 | 2021-06-09 | FORM 3 | 0001628280-26-002423 | View SEC Doc Filr Page |
| 10-Q | 2025-12-15 | 2025-10-31 | 10-Q | 0001628280-25-057082 | View SEC Doc Filr Page |
| 8-K | 2025-12-15 | 2025-12-15 | 8-K | 0001628280-25-057020 | View SEC Doc Filr Page |
| 4 | 2025-11-07 | 2025-11-05 | FORM 4 | 0001628280-25-050522 | View SEC Doc Filr Page |
| 4 | 2025-11-07 | 2025-11-05 | FORM 4 | 0001628280-25-050514 | View SEC Doc Filr Page |
| 4 | 2025-11-07 | 2025-11-05 | FORM 4 | 0001628280-25-050491 | View SEC Doc Filr Page |
| 4 | 2025-11-07 | 2025-11-05 | FORM 4 | 0001628280-25-050481 | View SEC Doc Filr Page |
| 4 | 2025-11-07 | 2025-11-05 | FORM 4 | 0001628280-25-050467 | View SEC Doc Filr Page |
| 4 | 2025-11-06 | 2025-10-30 | FORM 4 | 0001628280-25-049954 | View SEC Doc Filr Page |
| 8-K | 2025-10-16 | 2025-10-16 | 8-K | 0001628280-25-045241 | View SEC Doc Filr Page |
| 10-Q | 2025-09-15 | 2025-07-31 | 10-Q | 0000771856-25-000023 | View SEC Doc Filr Page |
| 8-K | 2025-09-15 | 2025-09-15 | 8-K | 0000771856-25-000022 | View SEC Doc Filr Page |